Frequency Therapeutics’ hearing loss treatment showed early signs of efficacy last year, with some patients showing improvements after a few months. Now, as the biotech plugs away at a phase 2a study, ...

An experimental regenerative therapy that Frequency Therapeutics was developing to treat a form of hearing loss has failed to beat a placebo in a clinical trial for the second time in two years, ...

Shape matters, even in hearing. Specifically, it is the shape of the cochlea – the snail-shell-shaped organ in the inner ear that converts sound waves into nerve impulses that the brain deciphers – ...

LEXINGTON, Mass.--(BUSINESS WIRE)--Frequency Therapeutics, Inc., (Nasdaq: FREQ) today shared a statement from David L. Lucchino, Frequency’s Chief Executive Officer, in support of the Hearing Loss ...